Friday, 9 May 2008 | Source: The Associated Press
A total of 335 Eli Lilly and Co. employees have accepted voluntary buyouts from the drug maker, and their jobs will end June 30, a spokesman said Friday.
Thursday, 8 May 2008 | Source: The Associated Press
Eli Lilly and Co. said Thursday the Food and Drug Administration approved its drug Strattera for maintenance of attention-deficit/hyperactivity disorder in children and adolescents.
Wednesday, 7 May 2008 | Source: The Associated Press
Shares of OSI Pharmaceuticals rose Wednesday, a day after the biotechnology company beat Wall Street expectations on higher sales of its cancer drug Tarceva.
Wednesday, 30 Apr 2008 | Source: The New York Times
A fight has erupted in Congress over the question of whether drug makers and other companies should be allowed to keep patents they obtained by misrepresentation or cheating, The New York Times reports.
Monday, 21 Apr 2008 | Source: CNBC.com
Merck and Eli Lilly reported earnings today, and CNBC asked the pharmaceutical companies’ chief executives and an analyst to discuss the results and the sector as a whole.
Monday, 21 Apr 2008 | Source: CNBC.com
Merck's revenues were light, but market reaction was positive. Eli Lilly's earnings were up sharply, but still disappointed the Street. So how does an investor play the results?
Monday, 21 Apr 2008 | Source: Reuters
Eli Lilly Monday posted lower-than-expected quarterly earnings, as disappointing sales of its Byetta diabetes drug overshadowed growing demand for its other medicines, sending shares 3.4 percent lower.
Wednesday, 9 Apr 2008 | Source: Reuters
Pfizer Inc. and Nektar Therapeutics said on Wednesday clinical trials of the inhaled insulin Exubera found increased cases of lung cancer, leading Nektar to end talks with potential partners to market the product.
Wednesday, 9 Apr 2008 | Source: Reuters
Pfizer and Nektar Therapeutics said Wednesday clinical trials of the inhaled insulin Exubera found increased cases of lung cancer, leading Nektar to end talks with potential partners to market the product.
Friday, 28 Mar 2008 | Source: CNBC.com
Ahead of the weekend, CNBC asks the experts where investors should place their bets.
Friday, 28 Mar 2008 | Source: CNBC.com
The pharmaceutical sector faces the looming "patent cliff" -- but Credit Suisse's Catherine Arnold finds lots of opportunities in the sector for the careful investor.
Friday, 29 Feb 2008 | Source: CNBC.com
The economy's worsening. So's inflation. And the stock market is tanking. What to do? CNBC asked market experts for their best investment advice. Here are some of their picks.
Friday, 29 Feb 2008 | Source: CNBC.com
There's nearly $3.5 trillion dollars waiting to be invested in the markets, according to Frederic Dickson, chief market strategist of D.A. Davidson. So what's keeping it out? And what should investors do in the meantime?
Thursday, 28 Feb 2008 | Source: Reuters
U.S. regulators have rejected a long-acting injectable form of Eli Lilly and Co's blockbuster schizophrenia drug Zyprexa, the company said Thursday, sending its shares down almost 2 percent.
Wednesday, 30 Jan 2008 | Source: The New York Times
abstract goes here
Posts |
COMPANY : Eli Lilly and Company
25 Apr 2008
The morning after Amgen reported its first quarter earnings my inbox runneth over with analyst research reports on the biotech behemoth... Read More
21 Apr 2008
The Dow pulled back Monday after a weaker-than-expected profit report from Bank of America stirred concerns about the health of corporate earnings... Read More
21 Apr 2008
Monday has not been a great day for bank earnings... Read More
18 Apr 2008
Was Pfizer's miss, a prescription for disaster in Big Pharma? Should you sell drug makers ahead of earnings next week?... Read More
18 Apr 2008
The irreverent producers of "Squawk on the Street" who are stationed in the pod next to mine here at CNBC like to call it "Pharmapalooza." They're referring to weeks like the one coming up when nearly every big drug company reports earnings... Read More
VIDEO | COMPANIES : Eli Lilly and Company
British factory gate prices and producers' costs continued to rise in April, official data showed Monday. Tom Vosa from ...
Latest data from China showed consumer price inflation rose again in April, taking the rate up to 8.5%. Arjuna Mahendran...
John Murray, MD of Perennial Value Management and Glenn Rosewall, CEO & MD from BBY expect more consolidation in Austral...
Boom time for the world's largest mining companies as a latest report from Ernst & Young says we're set to see a flurry ...
The infrastructure fund is the latest fad in a series of new propositions that the investment community have brought to ...
More Videos
HOME | NEWS | MARKETS | EARNINGS | INVESTING | VIDEO | CNBC TV | CNBC PLUS | CNBC HD+
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
(c) 2008 CNBC, Inc. All Rights Reserved
Data is a real-time snapshot *Data is delayed at least 15 minutes